RxDoctor Payments Data

Terrinda Alston

Nurse Practitioner · Norfolk, VANPI 1144601980

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 405 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,400, more than ten times the $32 reported in 2021. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,281in general payments, 2019–2025

Across 405 payments — averaging $25.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lumenis BE Inc$2K
  • Johnson & Johnson$931
  • Alkermes, Inc.$927
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$702
  • Otsuka America Pharmaceutical, Inc.$698
  • plus $4K from 17 others

What the payments were for

  • Food & beverage$10,268100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,281 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$7,073
Medicare patients
14
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Venlafaxine Hcl ErVenlafaxine Hcl25$611
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine26$461
Quetiapine Fumarate16$329
Zolpidem Tartrate30$282
Escitalopram Oxalate18$161
Buspirone Hcl22$153
Propranolol Hcl16$152
Trazodone Hcl17$150
Alprazolam23$130
Clonazepam27$116
Hydroxyzine Hcl16$112
Lamotrigine14$102
Fluoxetine Hcl22$81
Lorazepam11$70
Diazepam12$10

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →